depression nasal spray

FDA Approves ‘Spravato’ Nasal Spray

FDA-approved nasal spray for severe depression can lead to remission

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in people who have not responded to at least two oral antidepressants.

Hosted on MSN · 4d

FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult population.

Popular Science · 5d

FDA approves first-of-its-kind nasal spray for severe depression

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and similar psychiatric conditions.

Newsweek5d

FDA Approves Nasal Spray for Depression

This new treatment could help bring relief for millions of Americans struggling with depression. The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for ...

Does Medicare cover ketamine infusions for mental health conditions?

Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...

Can a nasal spray cure loneliness? Effects of hormone spritz lasted for months in study

Researchers delivered a dose of the “love hormone” oxytocin via a nasal spray to participants and found that it decreased ...

14hon MSN

U.S. children's dental care falls short at home, national poll reports

More than 1 in 3 parents reported that their child has dealt with dental problems linked to a lack of routine oral hygiene, ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results